지원사업
학술연구/단체지원/교육 등 연구자 활동을 지속하도록 DBpia가 지원하고 있어요.
커뮤니티
연구자들이 자신의 연구와 전문성을 널리 알리고, 새로운 협력의 기회를 만들 수 있는 네트워킹 공간이에요.
초록· 키워드
오류제보하기
“Breakthrough” of psychosis despite good compliance of antipsychotics medication for a long time is a major obstacle to the treat- ment of schizophrenia, whether the mechanism is caused by dopamine hypersensitivity or insufficient dose of antipsychotics. Researchers advocating “Dopamine Supersensitivity Psychosis” (DSP) emphasize to avoid excessive inhibition of dopamine 2 receptors from the beginning of treatment. On the other hand, researchers advocating “Breakthrough psychosis on Antipsychotic Maintenance Medication” (BAMM) in which psychosis recurs due to insufficient medication despite continuous administration of antipsychotics without non-adherence argue that dose of antipsychotics should be increased to enhance therapeutic effect. In patients using long-acting antipsychotics injection (LAI), non-compliance can be ruled out. We believe that in treating non-affec- tive psychosis, it is necessary to continuously maintain the lowest dose possible using the optimal dose considering the side effects of second-generation antipsychotics and the cycle and stage of psychosis, and the optimal formulation such as LAI
목차
등록된 정보가 없습니다.
참고문헌 (0)
참고문헌 신청함께 읽어보면 좋을 논문
논문 유사도에 따라 DBpia 가 추천하는 논문입니다. 함께 보면 좋을 연관 논문을 확인해보세요!
-
항정신병약물의 생물학적 기전 최신 지견
신경정신의학
2019 .01
-
Understanding of Antipsychotics in Elderly Patients with Dementia
Dementia and Neurocognitive Disorders(대한치매학회지)
2015 .01
-
Antipsychotic Prescribing Patterns in First-episode Schizophrenia: A Five-year Comparison
Clinical Psychopharmacology and Neuroscience
2015 .01
-
Efficacy of Asenapine in Drug-resistant Psychotic Patients with Dopamine Supersensitivity Psychosis: Two Cases
Clinical Psychopharmacology and Neuroscience
2023 .02
-
양극성장애에서 Antipsychotics의 사용 전략
신경정신의학
2018 .01
-
항정신병 약물의 병용요법을 사용 중인 환자들에서 아리피프라졸 장기 지속형 주사제의 효능
생물치료정신의학
2024 .10
-
A Systemic Review and Experts’ Consensus for Long-acting Injectable Antipsychotics in Bipolar Disorder
Clinical Psychopharmacology and Neuroscience
2015 .01
-
Diabetic Ketoacidosis Associated With Second Generation Antipsychotics: A Case Study and Review of Literature
PSYCHIATRY INVESTIGATION
2024 .02
-
Validation of the Korean Version of the Psychosis Screener to Identify Patients With Psychosis
PSYCHIATRY INVESTIGATION
2021 .08
-
조현병 약물치료의 최신 지견
대한의사협회지
2024 .02
-
Exploring Hidden Issues in the Use of Antipsychotic Polypharmacy in the Treatment of Schizophrenia
Clinical Psychopharmacology and Neuroscience
2021 .11
-
항정신병 약물 사용 및 치매의 심리행동 증상과 알츠하이머 환자의 인지능력 저하와의 연관성
노인정신의학
2021 .10
-
Neutropenia with Multiple Antipsychotics Including Dose Dependent Neutropenia with Lurasidone
Clinical Psychopharmacology and Neuroscience
2017 .01
-
조현병 환자에서 항정신병약물 유지치료 시 치료결과에 대한 연구
대한조현병학회지
2017 .10
-
‘2019 한국형 조현병 약물치료 지침서’에 따른 조현병에서 동반증상 및 부작용의 치료
대한조현병학회지
2019 .01
-
항정신병약물에 의한 대사부작용에 대한 이론과 대처방안
신경정신의학
2019 .01
-
Longer Telomere Length of T lymphocytes in Patients with Early and Chronic Psychosis
Clinical Psychopharmacology and Neuroscience
2017 .01
-
Design and Methodology of the Korean Early Psychosis Cohort Study
PSYCHIATRY INVESTIGATION
2017 .01
-
Quantitative Resting State Electroencephalography in Patients with Schizophrenia Spectrum Disorders Treated with Strict Monotherapy Using Atypical Antipsychotics
Clinical Psychopharmacology and Neuroscience
2021 .01
-
Effectiveness in Switching from Antipsychotic Polypharmacy to Monotherapy in Patients with Schizophrenia: A Case Series
Clinical Psychopharmacology and Neuroscience
2020 .01
이 논문의 저자 정보
최근 본 자료
댓글(0)
0